Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UVA, UVB "Reasonably Anticipated" To Be Human Carcinogens - NTP

This article was originally published in The Tan Sheet

Executive Summary

Ultraviolet A and B radiation are "reasonably anticipated to be human carcinogens based on limited evidence from studies in humans and evidence from studies in experimental animals," the National Toxicology Program's Board of Scientific Counselors ruled at its Report on Carcinogens Subcommittee meeting in Washington, D.C. Dec. 13-15.

You may also be interested in...



Supplement Composite Samples Best For NTP Study

The National Toxicology Program should use com-posite samples of products from multiple manufac-turers in its studies of dietary supplement ingredients, Clay Frederick, PhD, Rohm & Haas, suggested at the NTP Board of Scientific Counselors meeting in Research Triangle Park, N.C. May 25.

Supplement Composite Samples Best For NTP Study

The National Toxicology Program should use com-posite samples of products from multiple manufac-turers in its studies of dietary supplement ingredients, Clay Frederick, PhD, Rohm & Haas, suggested at the NTP Board of Scientific Counselors meeting in Research Triangle Park, N.C. May 25.

Supplement Composite Samples Best For NTP Study

The National Toxicology Program should use com-posite samples of products from multiple manufac-turers in its studies of dietary supplement ingredients, Clay Frederick, PhD, Rohm & Haas, suggested at the NTP Board of Scientific Counselors meeting in Research Triangle Park, N.C. May 25.

Topics

UsernamePublicRestriction

Register

PS092022

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel